← FDA DRUG APPROVALS

FDA ANDA · ANDA203150

QUETIAPINE FUMARATE

Sponsor: JUBILANT GENERICS

APPLICATION
ANDA203150
TYPE
ANDA
ORIGINAL APPROVAL
2013-11-26
LATEST ACTION
2021-11-09
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

QUETIAPINE FUMARATEDiscontinued
QUETIAPINE FUMARATE EQ 25MG BASE · TABLET · ORAL

Approval history

2021-11-09Labeling · Supplement 3 · standardAP
2021-11-09Labeling · Supplement 8 · standardAP
2021-11-09Labeling · Supplement 10 · standardAP
2015-05-04Labeling · Supplement 1 · standardAP
2013-11-26UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →